Guardion Health Sciences Analysis
| GHSIDelisted Stock | USD 3.29 0.04 1.23% |
Guardion Health Sciences is overvalued with Real Value of 3.13 and Hype Value of 3.29. The main objective of Guardion Health pink sheet analysis is to determine its intrinsic value, which is an estimate of what Guardion Health Sciences is worth, separate from its market price. There are two main types of Guardion Health's stock analysis: fundamental analysis and technical analysis.
The Guardion Health pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Guardion Health's ongoing operational relationships across important fundamental and technical indicators.
Guardion |
Guardion Pink Sheet Analysis Notes
About 21.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guardion Health Sciences recorded a loss per share of 4.11. The entity last dividend was issued on the 24th of September 2024. The firm had 1:50 split on the 9th of January 2023. Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. Guardion Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.The quote for Guardion Health Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Guardion Health Sciences call Janet Hall at 800 873 5141 or check out https://www.guardionhealth.com.Guardion Health Sciences Investment Alerts
| Guardion Health is not yet fully synchronised with the market data | |
| Guardion Health has a very high chance of going through financial distress in the upcoming years | |
| Guardion Health Sciences currently holds about 14.23 M in cash with (4.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23. |
Guardion Health Sciences Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Guardion Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Guardion Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guardion Health's market, we take the total number of its shares issued and multiply it by Guardion Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Guardion Profitablity
The company has Profit Margin (PM) of 0.52 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (18.75) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $18.75.Guardion Health Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardion Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardion Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Guardion Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Anderson Kelly over six months ago Acquisition by Anderson Kelly of 250000 shares of Guardion Health at 1.0 subject to Rule 16b-3 | ||
Great Point Capital Llc over six months ago Disposition of tradable shares by Great Point Capital Llc of Guardion Health subject to Rule 16b-3 | ||
Gagliano Donald A over a year ago Acquisition by Gagliano Donald A of 334 shares of Guardion Health subject to Rule 16b-3 |
Guardion Health Outstanding Bonds
Guardion Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Guardion Health Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Guardion bonds can be classified according to their maturity, which is the date when Guardion Health Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
About Guardion Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Guardion Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Guardion shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Guardion Health. By using and applying Guardion Pink Sheet analysis, traders can create a robust methodology for identifying Guardion entry and exit points for their positions.
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. Guardion Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Guardion Health to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |